ATLASATLAS fair value
ATLAS has no fair value for this stock today.
BioArctic AB (publ) (BIOA-B.ST)
BioArctic AB (publ) stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Nasdaq Stockholm · Sweden
SEK 313.80▲ +1.82%
Prices as of Oct 27, 2026 · SEK
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BioArctic AB (publ) in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BioArctic AB (publ)
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives BioArctic AB (publ) a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 291.67 and SEK 336.67; in 9 out of 10, between SEK 256.83 and SEK 382.34. Estimated annual volatility is 34%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 26.1B
- Market cap (USD)
- $2.6B
- P/E ratio
- 263.2
- Dividend yield
- 0.69%
- 52-week high
- SEK 364.40
- 52-week low
- SEK 257.00
- Revenue (12 months)
- SEK 1.0B
- Gross margin
- 93.2%
- Operating margin
- -5.8%
- Net margin
- 10.5%
- Beta
- -0.65
What this means
ATLAS does not publish a fair value for BIOA-B.ST right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BIOA-B.ST has traded between SEK 257.00 and SEK 364.40. Today it is 13.9% below that high and 22% above its low.
On the business: net margin is 10.5%; it trades at 263.2 times earnings.
Its beta is -0.65: it tends to move less than the market.
About the company
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of biological drugs, such as antibodies that address high unmet medical needs.
Want to see everything about BioArctic AB (publ)?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does BioArctic AB (publ) do?
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of biological drugs, such as antibodies that address high unmet medical needs.
What is the chance BIOA-B.ST goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, BIOA-B.ST ends the month between SEK 291.67 and SEK 336.67.
How big is BioArctic AB (publ) and what is its P/E ratio?
BioArctic AB (publ)'s market capitalization is SEK 26.1B. Its price-to-earnings (P/E) ratio is 263.2: you pay SEK 263.2 for each SEK 1.00 of yearly earnings.
Does BioArctic AB (publ) pay a dividend?
Yes. BIOA-B.ST's current dividend yield is 0.69% at today's price (SEK 313.80).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer